Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860516 · ClinicalTrials.gov registry record
HLA Demographics Study in Adults With Type 1 Diabetes
A clinical trial of Diabetes Mellitus, Type I, sponsored by GentiBio.
- Recruiting
- Registry status
- 50
- Enrollment target
- 5
- Study locations
NCT06860516 is a study of Diabetes Mellitus, Type I that is actively recruiting participants, run by GentiBio. The registered enrollment target is 50 participants, below the 141-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (65% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06860516, a study of Diabetes Mellitus, Type I, is actively recruiting participants, sponsored by GentiBio.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (5)
California
- University of California, San Francisco - San Francisco
Florida
- University of Florida- Gainesville - Gainesville
Massachusetts
- Joslin Diabetes Center - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06860516
The ClinicalTrials.gov registry entry for NCT06860516 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 5 other Diabetes Mellitus, Type I trials with a reported enrollment target (65% lower). The listed sponsor is GentiBio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type I appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT06860516 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06860516 about?
NCT06860516 is a clinical study titled "HLA Demographics Study in Adults With Type 1 Diabetes". This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
What is the current status of trial NCT06860516?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-06-06. Estimated completion is 2026-06.
What conditions does trial NCT06860516 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type I.
What interventions are being tested in trial NCT06860516?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT06860516?
This trial is sponsored by GentiBio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860516 being conducted?
This trial has 5 study locations across California, Florida, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type I
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
RECRUITING · NA
-
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
ACTIVE NOT RECRUITING · Phase 2
-
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
COMPLETED
-
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
COMPLETED · NA
-
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.